摘要
目的观察复方牛胎肝提取物片治疗慢性乙型肝炎患者对肝纤维化指标的影响。方法选取153例慢性乙型肝炎患者,分别给予复方牛胎肝提取物、复方鳖甲软肝片和一般护肝治疗,观察3个月。结果复方牛胎肝提取物和复方鳖甲软肝片治疗患者肝功能指标改善,明显优于对照组;两组患者血清HA、LN、PcIII、cIV、血清TIMP-2和HYP水平明显下降,优于对照组;复方牛胎肝提取物与复方鳖甲软肝片治疗患者的上述指标变化无显著性差异。结论复方牛胎肝提取物能有效降低患者肝纤维化指标,改善患者肝功能,有明显的抗肝纤维化疗效。
Objective To observe the therapeutic effects of embryonic bovine liver extract compound on hepatic fibrosis in patients with chronic hepatitis B. Methods 153 patients with CHB were divided randomly into three groups receiving embryonic bovine liver extract compound,BieJiaR, uanGan and conventional therapy,respectively,for three months. Results The indexes of liver function and of hepatic fibrosis improved or decreased after treatment of the two regimen. There was no side effects in the two treatments. Conclusion Embryonic bovine liver extract compound can decrease effectively the indexes of hepatic fibrosis and improve the liver function in patients with CHB.
出处
《实用肝脏病杂志》
CAS
2010年第1期37-38,33,共3页
Journal of Practical Hepatology
